Belfast's B-Secur has launched an electrocardiogram (EKG/ECG) solution based on the Texas Instruments (TI) AFE4950 analog front end (AFE) for photoplethysmography (PPG) and EKG/ECG sensing that will accelerate the design of next-generation consumer wearables.

The integration provides high-performing sensing capabilities for wearable devices like premium smartwatches and Wi-Fi-connected optical heart-rate monitors, and enables advanced features for identification, wellness and health monitoring in Internet of Things (IoT) devices.

It is the industry's first solution with a fully integrated EKG/ECG and PPG signal chain that allows for synchronous sampling of cardiac activity with dry electrodes used in battery-operated products.

-- Advertisement --

It follows an announcement from B-Secur that it has received U.S. Food and Drug Administration (FDA) clearance for its innovative HeartKey® ECG/EKG software.

The combination of HeartKey® and TI's AFE4950 enables device manufacturers and partners around the world to eliminate months of R&D with a fully integrated sensor, electrical and signal processing solution. It is a key development enabling heart-health features to become widely available in the fast-paced and rapidly evolving consumer wearables sector.

The collaboration is part of B-Secur's drive to speed up the development and adoption of high-performance biosensing solutions by device manufacturers worldwide.

"It is a key strategic development for B-Secur to announce this integration with Texas Instruments and our FDA-cleared HeartKey® software today. As more and more wearable and IoT devices adopt ECG/EKG technology, supplying a fully integrated, high-performance solution with Texas Instruments means our customers around the world can bring their own consumer wearable products to market quicker and with greater confidence," said Ben Carter, CCO, B-Secur